Logo
Login
$ISRG
$451.69 -$0.60 (0.13%) Live

Company Executives

$ISRG Management Team

Mr. Brian Miller

Head of Digital and AI Strategy

Age 50
Compensation $6.197M USD
Sex Male

Mr. Mark Brosius

Senior Vice President

Chief Manufacturing and Supply Chain Officer

Age 58
Compensation -
Sex Male

Dr. Gary Guthart

Executive Chairman of the Board

Age 59
Compensation $18.20M USD
Sex Male

Mr. Jamie Samath

Executive Vice President

Chief Financial Officer

Head of Business Technology

Age 55
Compensation $7.034M USD
Sex Male

Mr. Bob DeSantis

Executive Vice President

Chief Strategy and Corporate Operations Officer

Age 60
Compensation $4.838M USD
Sex Male

Mr. David Rosa

Chief Executive Officer

Director

Age 57
Compensation $13.76M USD
Sex Male

Mr. Henry Charlton

Executive Vice President

Chief Commercial and Marketing Officer

Age 55
Compensation $6.468M USD
Sex Male

Mr. Gary Loeb

Executive Vice President

Chief Legal and Compliance Officer

Age 55
Compensation -
Sex Male

Dr. Myriam Curet

Executive Vice President

Chief Medical Officer

Age 68
Compensation $4.481M USD
Sex Female

Board of Directors

From the proxy statement filed Mar 13, 2026
Directors
11
serving now
Independent
9 of 11
stated in the proxy
Average tenure
7.6 years
from year joined
CEO also chairs the board
No
Gary S. Guthart, Ph.D.
Director Age On board Independent Committees Other public boards 2025 pay Source
Craig H. Barratt, Ph.D.
Lead independent director
 63 2011
15 years
 Independent
Governance and Nominating
Intel Corporation (Nasdaq: INTC) $465,385
Joseph C. Beery
63 2020
6 years
 Independent
Governance and Nominating
None stated $352,123
Lewis Chew
63 2024
2 years
 Independent
Audit · Chair
Arista Networks (NYSE: ANET) $369,623
Gary S. Guthart, Ph.D.
Board chair
 60 2009
17 years
 Not independent None stated Illumina, Inc (Nasdaq: ILMN) Not stated
Sreelakshmi Kolli
51 2023
3 years
 Independent
Audit
Zimmer Biomet (NYSE: ZBH) $357,123
Amy L. Ladd, M.D.
68 2019
7 years
 Independent
Compensation
None stated $354,623
Keith R. Leonard, Jr.
64 2016
10 years
 Independent
Audit
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) $357,123
Jami Dover Nachtsheim
67 2017
9 years
 Independent
Governance and Nominating · Chair
Cerus Corporation (Nasdaq: CERS) $359,623
Monica P. Reed, M.D.
63 2021
5 years
 Independent
Compensation · Chair
None stated $359,623
David J. Rosa
CEO
 58 2024
2 years
 Not independent None stated None stated Paid as CEO
Amal M. Johnson
Not stated Not stated Independent None stated None stated $359,623

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Mar 13, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans